A Los Angeles Superior Court has denied Medtronic Inc's motions for summary judgment in two separate lawsuits involving its MiniMed insulin pump systems, allowing legal proceedings to continue based on allegations of fraudulent concealment.
Judge Elihu Berle's ruling in the complex litigation cases, *Davis et al. v. Medtronic MiniMed Inc.* and *Burgess et al. v. Medtronic MiniMed Inc.*, found sufficient evidence that the medical device manufacturer may have deliberately concealed known defects in its insulin pump retainer rings.
The court's order suggests Medtronic potentially possessed internal documentation indicating awareness of defective components as early as 2016. Judge Berle noted that the evidence could support claims that the company intentionally continued selling pump systems while knowing about potential risks to users.
Specifically, the judge highlighted evidence implying Medtronic's actions were motivated by continuing product sales and avoiding liability for potential user harm. The ruling provides a pathway for over 1,000 Type-I diabetic plaintiffs represented by Cowper Law LLP to pursue their legal claims.
The cases are currently scheduled for trial on July 21, 2025, potentially representing a significant legal challenge for Medtronic and potential implications for medical device accountability and patient safety.
